Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)

Detalles Bibliográficos
Autores principales: Lin, Tzu-Yi, Kang, Eugene Yu-Chuan, Shao, Shih-Chieh, Lai, Edward Chia-Cheng, Hwang, Yih-Shiou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2023
Materias:
Response
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404523/
https://www.ncbi.nlm.nih.gov/pubmed/37533200
http://dx.doi.org/10.4093/dmj.2023.0188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404523/
https://www.ncbi.nlm.nih.gov/pubmed/37533200
http://dx.doi.org/10.4093/dmj.2023.0188

Ejemplares similares